Bio-Rad Laboratories, Inc. Share Price Nyse
Equities
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
279.9 USD | 0.00% | 0.00% | -12.71% |
08/05 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
08/05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
Sales 2024 * | 2.66B 222B | Sales 2025 * | 2.79B 233B | Capitalization | 8.03B 671B |
---|---|---|---|---|---|
Net income 2024 * | 294M 24.55B | Net income 2025 * | 285M 23.79B | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | 674M 56.3B | Net cash position 2025 * | 828M 69.11B | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
28.2
x | Employees | 8,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.02% |
Latest transcript on Bio-Rad Laboratories, Inc.
3 months | -14.78% | ||
6 months | -8.79% | ||
Current year | -12.71% |
Managers | Title | Age | Since |
---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 74 | 01/89/01 |
Gregory Hinckley
DFI | Director of Finance/CFO | 77 | 01/83/01 |
Andrew Last
COO | Chief Operating Officer | 64 | 22/19/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 25/17/25 |
Alice Schwartz
FOU | Founder | 97 | 01/52/01 |
Gregory Hinckley
BRD | Director/Board Member | 77 | 25/17/25 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 279.9 | 0.00% | 0 |
09/24/09 | 279.9 | 0.00% | 0 |
08/24/08 | 279.9 | 0.00% | 0 |
07/24/07 | 279.9 | 0.00% | 0 |
06/24/06 | 279.9 | 0.00% | 0 |
Delayed Quote Nyse, May 11, 2024 at 01:45 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock